세계의 원격 환자 모니터링 시스템 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 용도별, 지역별, 부문별 예측(2025-2033년)

Remote Patient Monitoring System Market Summary

The global remote patient monitoring system market size was estimated at USD 22.03 billion in 2024 and is projected to reach USD 110.71 billion by 2033, growing at a CAGR of 19.8% from 2025 to 2033. The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker thus boosting its demand in the coming years at a global level.

The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker thus boosting its demand in the coming years at a global level. The COVID-19 pandemic led to a shortage of space in hospitals. Apart from this, patients, especially those suffering from chronic diseases, were advised to avoid physical visits to hospitals owing to the threat of getting infected. This led to the development of remote patient monitoring market.

Firms make a large number of investments by collaborating, acquiring, and partnering with new emerging startups. The personalized telemedicine app provides a communication platform for remote and real-time monitoring of patients that acts as a bridge between caregiver and patient. This step-change, borne out of necessity, changed the entire look of the remote patient monitoring market post-COVID-19. This change has sped up recovery rates as consumers are more willing to join the app. It has also increased the provider's willingness to use the app, and it offers greater access and reimbursements.

Global Remote Patient Monitoring System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global remote patient monitoring systems market report based on product, application, end use and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Vital Sign Monitors
  • Blood Pressure Monitors
  • Pulse Oximeters
  • Heart Rate Monitor (ECG)
  • Temperature Monitor
  • Respiratory Rate Monitor
  • Brain Monitoring (EEG)
• Special Monitors
  • Anesthesia Monitors
  • Blood Glucose Monitors
  • Cardiac Rhythm Monitor
  • Respiratory Monitor
  • Fetal Heart Monitors
  • Prothrombin Monitors
  • Multi Parameter Monitors (MPM)
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cancer
• Cardiovascular Diseases
• Diabetes
• Sleep Disorder
• Weight management and Fitness Monitoring
• Bronchitis
• Infections
• Virus
• Dehydration
• Hypertension
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals Based Patients
• Ambulatory Patients
• Home Healthcare
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Remote Patient Monitoring Systems Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Pricing Model Analysis
  • 3.2.1. Subscription-Based Pricing (Annual or Monthly)
  • 3.2.2. Usage-Based or Pay-Per-Interaction
  • 3.2.3. Volume-Based Discount Model
  • 3.2.4. Bundled Pricing Model
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing Prevalence of Chronic Diseases
    • 3.3.1.2. Rising adoption of telehealth and digital health platforms
    • 3.3.1.3. Technological advancements in wearable and connected devices
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Data Security and Privacy Concerns
    • 3.3.2.2. Limited reimbursement policies and regulatory variability across regions
• 3.4. Surgical Instrument Tracking Systems: Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTLE Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic landscape
    • 3.4.2.3. Social landscape
    • 3.4.2.4. Technological landscape
    • 3.4.2.5. Environmental landscape
    • 3.4.2.6. Legal landscape
• 3.5. Regulatory Landscape
• 3.6. Technology Overview
• 3.7. Case Study Analysis

Chapter 4. Remote Patient Monitoring Systems Market Segment Analysis, By Product Type, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Remote Patient Monitoring Systems Market, by Product, 2021 to 2033
  • 4.4.1. Vital Sign Monitors
    • 4.4.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.2. Blood Pressure Monitors
      • 4.4.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.3. Pulse Oximeters
      • 4.4.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.4. Heart Rate Monitor
      • 4.4.1.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.5. Temperature Monitors
      • 4.4.1.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.6. Respiratory Rate Monitors
      • 4.4.1.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.1.6.1.1. Canographs
          • 4.4.1.6.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.1.6.1.2. Spirometers
          • 4.4.1.6.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.7. Brain Monitoring (EEG)
      • 4.4.1.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Special Monitors
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.1. Anesthesia Monitor
      • 4.5.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.2. Blood Glucose Monitor
      • 4.5.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.3. Cardiac Rhythm Monitor
      • 4.5.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.4. Respiratory Monitor
      • 4.5.1.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.5. Fetal Heart Monitor
      • 4.5.1.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.6. Prothrombin Monitor
      • 4.5.1.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.7. Multi Parameter Monitor
      • 4.5.1.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.8. Others Monitor
      • 4.5.1.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Remote Patient Monitoring Systems Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Remote Patient Monitoring Systems Market, by Application, 2021 to 2033
• 5.5. Cancer
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Cardiovascular Diseases
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Diabetes
  • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Sleep Disorder
  • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Weight Management and Fitness Monitoring
  • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Bronchitis
  • 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.11. Infections
  • 5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.11.1.1. Eye infections
      • 5.11.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.11.1.2. Sinus Infections
      • 5.11.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.11.1.3. Strep Throat
      • 5.11.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.12. Virus
  • 5.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.13. Dehydration
  • 5.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.14. Hypertension
  • 5.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Remote Patient Monitoring Systems Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End use Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Remote Patient Monitoring Systems Market, by End Use, 2021 to 2033
• 6.5. Hospital-based patients
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Ambulatory patients
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Home Healthcare
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Remote Patient Monitoring Systems Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Remote Patient Monitoring Systems Market Share by Region, 2024 & 2033:
• 7.5. North America
  • 7.5.1. North America remote patient monitoring systems market, 2021 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico remote patient monitoring systems market, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark remote patient monitoring systems market, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand remote patient monitoring systems market, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina remote patient monitoring systems market, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE remote patient monitoring systems market, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait remote patient monitoring systems market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2024 (%)
• 8.4. Company Profiles
  • 8.4.1. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Solution Type benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Nihon Kohden Corporation
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Solution Type benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Omron Corporation
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Solution Type benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. OSI Systems, Inc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Solution Type benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Koninklijke Philips N.V.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Solution Type benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. F. Hoffmann-La Roche Ltd
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Solution Type benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Welch Allyn
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Solution Type benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Smiths Medical
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Solution Type benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Abbott
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Solution Type benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Informatica Boston Scientific Corporation
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Solution Type benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Drager Medical
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Solution Type benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. GE Healthcare
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Solution Type benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Honeywell
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Solution Type benchmarking
    • 8.4.13.4. Strategic initiatives
  • 8.4.14. Johnson & Johnson
    • 8.4.14.1. Company overview
    • 8.4.14.2. Financial performance
    • 8.4.14.3. Solution Type benchmarking
    • 8.4.14.4. Strategic initiatives
  • 8.4.15. LifeWatch
    • 8.4.15.1. Company overview
    • 8.4.15.2. Financial performance
    • 8.4.15.3. Solution Type benchmarking
    • 8.4.15.4. Strategic initiatives
  • 8.4.16. Medtronic
    • 8.4.16.1. Company overview
    • 8.4.16.2. Financial performance
    • 8.4.16.3. Solution Type benchmarking
    • 8.4.16.4. Strategic initiatives
  • 8.4.17. Masimo
    • 8.4.17.1. Company overview
    • 8.4.17.2. Financial performance
    • 8.4.17.3. Solution Type benchmarking
    • 8.4.17.4. Strategic initiatives
  • 8.4.18. Vitls, Inc
    • 8.4.18.1. Company overview
    • 8.4.18.2. Financial performance
    • 8.4.18.3. Solution Type benchmarking
    • 8.4.18.4. Strategic initiatives
  • 8.4.19. CareValidate
    • 8.4.19.1. Company overview
    • 8.4.19.2. Financial performance
    • 8.4.19.3. Solution Type benchmarking
    • 8.4.19.4. Strategic initiatives
  • 8.4.20. Biotronik
    • 8.4.20.1. Company overview
    • 8.4.20.2. Financial performance
    • 8.4.20.3. Solution Type benchmarking
    • 8.4.20.4. Strategic initiatives
  • 8.4.21. American Telecare
    • 8.4.21.1. Company overview
    • 8.4.21.2. Financial performance
    • 8.4.21.3. Solution Type benchmarking
    • 8.4.21.4. Strategic initiatives